This inventor holds 1 USPTO granted patent. Top assignee: Academia Sinica. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations by Fan-Dan Jan: Pioneering Protein Carriers for Immune Responses
Introduction: Fan-Dan Jan is an accomplished inventor based in Chiayi County, Taiwan. He has made notable contributions to scientific research through his innovative work in the field of immunology. With a solid understanding of protein engineering, he has created inventions that have the potential to enhance immune responses against various diseases.
Latest Patents: Fan-Dan Jan holds a patent for an "Immunogenic Protein Carrier Containing an Antigen Presenting Cell Binding Domain and a Cysteine-Rich Domain." This groundbreaking patent describes a novel protein carrier that includes an antigen presenting cell binding domain alongside a cysteine-rich domain. Additionally, the patent outlines an immunoconjugate composed of the protein carrier with an antigen conjugated to multiple cysteine residues within the cysteine-rich domain. The invention also encompasses an immune composition that consists of the immunoconjugate and an adjuvant, highlighting its potential uses in eliciting robust immune responses.
Career Highlights: Fan-Dan Jan is associated with Academia Sinica, a prestigious research institution in Taiwan renowned for its contributions to scientific advancements. His work has garnered attention for its innovative approach to immunology and its implications for vaccine development.
Collaborations: Throughout his career, Fan-Dan Jan has collaborated with esteemed colleagues such as Jaulang Hwang and Chun-Cheng Lin. These partnerships have played a crucial role in advancing his research and enhancing the efficacy of his inventions.
Conclusion: As an inventor, Fan-Dan Jan continues to innovate and contribute to the field of immunology. His patented work on immunogenic protein carriers demonstrates his commitment to developing strategies that can significantly impact public health by improving vaccine efficacy and immune responses. His collaborations and association with Academia Sinica position him well to influence future research in this vital area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile